MOTIV Study. Effect of Antidepressive Treatment by Escitalopram Started Preoperatively in Patients Undergoing Coronary Artery Bypass Grafting
Phase of Trial: Phase IV
Latest Information Update: 01 May 2013
At a glance
- Drugs Escitalopram (Primary)
- Indications Depressive disorders
- Focus Therapeutic Use
- Acronyms MOTIV; MOTIV-CABG
- 16 Mar 2012 Actual patient number (368) added as reported by ClinicalTrials.gov.
- 16 Mar 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 16 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History